Premium
Nitroglycerin ameliorates liver injury and regulates adaptive immunity in mice
Author(s) -
Zhao Shuang,
Lu ZhongHua,
Cui JuanJuan,
Li Dong,
Zhu YiLing,
Gan JianHe
Publication year - 2020
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/ddr.21653
Subject(s) - malondialdehyde , carbon tetrachloride , liver injury , glutathione , medicine , pharmacology , alanine aminotransferase , chemistry , oxidative stress , enzyme , biochemistry , organic chemistry
This study aimed to assess the protective effect of nitroglycerin, a commonly used drug in cardiovascular diseases, on mice with acute liver injury induced by carbon tetrachloride (CCl 4 ). The mice were randomly divided into three groups: control, CCl 4 , and CCl 4 + nitroglycerin. They were killed at 0, 6, 12, 24, and 48 h after treatment. Blood and liver tissue samples were collected for analysis. Analysis of the amounts of serum alanine aminotransferase (ALT)/aspartate aminotransferase (AST), hepatic glutathione (GSH), and malondialdehyde (MDA) showed that nitroglycerin protected against CCl 4 ‐induced acute liver injury. Liver histological analysis provided further evidence of the protective effect of nitroglycerin. Furthermore, we found that nitroglycerin suppressed the increase of T helper 17 (Th17) cells in CCl 4 ‐induced acute liver injury mice. The results indicate that nitroglycerin is a potential candidate for hepatic disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom